Thanks to four international research facilities, we can maintain a high level in the development and manufacture of innovative new drugs. Our plants are located in Paris (France), Rockville (USA), Chippenham (England) and Parma (Italy).
The plant in Parma opened in 2011 and includes units for preclinical, clinical, registration and pharmacovigilance. In addition, it features state of the art drug manufacturing facilities with an annual production of over 52 million product units. Great effort has gone into creating a facility that saves energy and minimizes environmental impact. The plant in Parma was awarded the Facility of the Year Award by ISPE, Interphex and Pharmaceutical Processing Magazine.